IGC Pharma
29 hedge funds and large institutions have $7.97M invested in IGC Pharma in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.2% more ownership
Funds ownership: 7.62% → 9.81% (+2.2%)
11% less call options, than puts
Call options by funds: $805K | Put options by funds: $905K
Holders
29
Holding in Top 10
–
Calls
$805K
Puts
$905K
Top Buyers
| 1 | +$1.5M | |
| 2 | +$391K | |
| 3 | +$212K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$119K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$101K |
Top Sellers
| 1 | -$223K | |
| 2 | -$62.1K | |
| 3 | -$45K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$44K |
| 5 |
VF
Virtu Financial
New York
|
-$33K |